Cargando…
Foxa2 and Cdx2 cooperate with Nkx2-1 to inhibit lung adenocarcinoma metastasis
Despite the fact that the majority of lung cancer deaths are due to metastasis, the molecular mechanisms driving metastatic progression are poorly understood. Here, we present evidence that loss of Foxa2 and Cdx2 synergizes with loss of Nkx2-1 to fully activate the metastatic program. These three li...
Autores principales: | Li, Carman Man-Chung, Gocheva, Vasilena, Oudin, Madeleine J., Bhutkar, Arjun, Wang, Shi Yun, Date, Saya R., Ng, Sheng Rong, Whittaker, Charles A., Bronson, Roderick T., Snyder, Eric L., Gertler, Frank B., Jacks, Tyler |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573857/ https://www.ncbi.nlm.nih.gov/pubmed/26341558 http://dx.doi.org/10.1101/gad.267393.115 |
Ejemplares similares
-
Isoform-specific deletion of PKM2 constrains tumor initiation in a mouse model of soft tissue sarcoma
por: Dayton, Talya L., et al.
Publicado: (2018) -
Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma
por: Dayton, Talya L., et al.
Publicado: (2016) -
Suppression of Lung Adenocarcinoma Progression by Nkx2-1
por: Winslow, Monte M., et al.
Publicado: (2011) -
FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer
por: Camolotto, Soledad A, et al.
Publicado: (2018) -
NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors
por: Yang, Michelle X., et al.
Publicado: (2018)